Clinical samples further confirmed the co-upregulation of NIBAN2, FLII, and RREB1 in GBM (Glioblastoma) tissues, which correlates with SOX2 and Ki-67 expression and poor prognosis. This evidence concerns the gene NIBAN2 and glioblastoma.